Inivata appoints Charlie Kesinger as CIO

2018, News

Inivata, a leader in liquid biopsy, today announces the appointment of Charlie Kesinger as Chief Information Officer. 

Prior to joining Inivata, Mr Kesinger led international technology operations at D-Wise, a consulting firm focusing on healthcare and life sciences. Before this he headed IT Excellence & Reliability for Medsolutions, a billion-dollar healthcare-based decision support organization. Mr Kesinger also served as a Chief Operations Officer at Emergisoft, a healthcare-based electronic medical records management company where he delivered systems to enterprise clients and successfully launched electronic medical records for maritime. He holds a Master of Science (Medical Informatics) from Northwestern University and is currently concluding his Ph.D. in Organizational Leadership.

Clive Morris, Chief Executive Officer at Inivata, said: 

“Effective data management and IT platforms are key to Inivata’s success and we are confident Charlie’s extensive experience will prove invaluable as we continue to build scale in our commercial platform and engagement with partners in the pharmaceutical and biotechnology industry.”

 

About Inivata

Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood draw to guide and personalize cancer treatment, monitor response and detect relapse. Inivata’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge. Its lead product, InVisionFirst®-Lung is commercially available and offers best-in-class sensitivity and turnaround, providing molecular insights that enable clinicians to make more informed treatment decisions for advanced NSCLC patients. Inivata has also launched the personalized RaDaR™ assay – allowing the highly sensitive detection of residual disease and recurrence. Inivata is partnering with pharmaceutical, biotechnology companies and commercial partners in a range of early and late stage cancer development programs. The Company has a CLIA certified, CAP accredited laboratory in Research Triangle Park, NC and R&D laboratories in Cambridge, UK. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata.

 

Media Contacts

Consilium Strategic Communications

Chris Gardner/Angela Gray/Sarah Wilson

Paul Rabin (US)

inivata@consilium-comms.com +44 (0)20 3709 5700, +1 516 503 0271

 

Karen Chandler-Smith

karen.chandler-smith@inivata.com +44 (0)7900 430235

 

Our Technology

Our Solutions

Latest News